Publication | Open Access

Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort

GlomerulonephritisUrologyRenal FunctionAutoimmune DiseaseLupusLupus NephritisIga GlomerulonephritisChronic Kidney DiseaseAdd-on BelimumabDurable Renal ResponseMedicineNephrology